NL-OMON42845
Recruiting
Phase 2
Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients with Localized Prostate Cancer: a Prospective, Single-Arm, Pivotal Clinical Study - MRI-TULSA-PRO
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Prostate cancer
- Sponsor
- Profound Medical, Inc.
- Enrollment
- 12
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Men diagnosed with biopsy\-proven, organ\-confined, low\- to intermediate\-risk prostate cancer will be eligible for participation in this study, provided they have not received prior treatment of their prostate cancer.
Exclusion Criteria
- •Extraprostatic extension, lesion within 3mm of the urethra or sphincter plane, previous TURP, calcifications or cysts in the prostate, use of hormones
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Pivotal Study of MRI-guided Transurethral Ultrasound Ablation in Patients With Localized Prostate CancerProstate CancerNCT02766543Profound Medical Inc.150
Completed
Not Applicable
MRI-guided transurethral ultrasound ablation in patients with localized prostate cancerC61Malignant neoplasm of prostateDRKS00017242niversitätsklinikum Dresden, Klinik und Poliklinik für Strahlentherapie und Radioonkologie6
Not yet recruiting
Not Applicable
significance of TRUS and MRI in complex fistula in anoHealth Condition 1: K603- Anal fistulaCTRI/2022/07/043623Department of Shalya Tantra
Completed
Not Applicable
Safety Study of MRI-guided Transurethral Ultrasound Ablation of Prostate Tissue to Treat Localized Prostate CancerProstate CancerNCT01686958Profound Medical Inc.30
Not yet recruiting
Not Applicable
Role of abdominal block for postoperative pain relief after total abdominal hysterectomy.Health Condition 1: null- Postoperative painCTRI/2018/01/011163Tata Motors Hospital